Companies / Idera Pharmaceuticals, Inc.
Idera Pharmaceuticals, Inc.
ACGNIDRACIK 861838
Activity
InsidersInstitutions
What the company's own insiders are buying and selling.| Date | Actor | Action | Security | Value | Shares Δ | Position after | Impact |
|---|---|---|---|---|---|---|---|
| Feb 13, 2015 | Baker Julian Director | Buy Open-market buy | Common Stock | $18.37M | +4.9M +343.64% | 6,323,855 | high |
| Mar 18, 2021 | Pillar Invest Corp 10% owner | Sell Open-market sale | Common Stock | $2.47M | +1.4M +50.12% | 4,121,599 | medium |
| Feb 13, 2015 | Baker Julian Director | Buy Open-market buy | Common Stock | $1.63M | +435K +228.22% | 625,495 | high |
| Mar 18, 2021 | Pillar Invest Corp 10% owner | Sell Open-market sale | Common Stock | $582.2K | +324K +25.20% | 1,608,167 | medium |
| Jun 1, 2021 | Dougherty Michael R Director | Buy Open-market buy | Common Stock | $101.2K | +85K +174.95% | 133,584 | medium |
| Jan 6, 2023 | Lim Bryant David Executive | Other Withheld for taxes | Common Stock | $85.2K | -120K -27.92% | 309,695 | low |
| Jan 6, 2023 | Kirby John J. Executive | Other Withheld for taxes | Common Stock | $85.2K | -120K -27.46% | 316,893 | low |
| Jun 18, 2021 | Soland Daniel B Executive | Buy Open-market buy | Common Stock | $59.5K | +50K +173.35% | 78,843 | medium |